Abstracts Archive - Page 186 of 1683 - ATC Abstracts

2022 American Transplant Congress
T and B Cell Response to 3 Dose Covid Vaccine Series for Kidney Transplant Patients on Belatacept
J. Christensen¹, I. Yakubu², D. Kumar¹, D. Cornett³, M. A. Miller³, M. Altrich³, L. Flebbe-Rehwaldt³, R. Thompson¹, G. Gupta¹
¹Internal Medicine, Transplant Nephrology, VCUHealth, Richmond, VA, ²Pharmacy, VCUHealth, Richmond, VA, ³Eurofins Viracor, Lee's Summit, MO
*Purpose: Data shows COVID vaccine response after 2 doses in patients on Belatacept immunosuppression (IS) is low, with reported rates of seroconversion (as measured by…
2022 American Transplant Congress
The Impact of New-Onset Diabetes After Transplantation on Survival and Major Cardiovascular Events in Korean Kidney Transplantation Recipients
E. Kang¹, J. Lee², D. Kang³, Y. Jang⁴, S. Park⁵, Y. Kim⁴, D. Kim⁴, K. Joo⁴, Y. Kim⁴, M. Park⁶, Y. Lim⁷, H. Lee⁴
¹Ewha Womans University Seoul Hospital, Seoul, Korea, Republic of, ²Dongguk University Ilsan Hospital, Goyang, Korea, Republic of, ³Chung-Ang University, Seoul, Korea, Republic of, ⁴Seoul National University Hospital, Seoul, Korea, Republic of, ⁵Seoul National University College of Medicine, Seoul, Korea, Republic of, ⁶Informations and Statistics, Chungnam National University, Daejeon, Korea, Republic of, ⁷Applied Statistics, Chung-Ang University, Seoul, Korea, Republic of
*Purpose: New-onset diabetes after transplantation (NODAT) is a frequent complication in kidney transplant (KT) recipients with unfavorable outcomes, although a nationwide study on epidemiology and…
2022 American Transplant Congress
Histologic Predictors of Graft Loss in Early Clinically Indicated Biopsies After Kidney Transplantation
M. Ajaimy¹, V. Hemmige², L. E. Liriano-Ward³, Y. Azzi¹, S. Kapoor⁴, P. Loarte¹, C. Pynadath⁵, A. Colovai¹, E. Akalin⁶
¹Einstein-Montefiore Transplant Center, Bronx, NY, ²Montefiore Medical Center, Bronx, NY, ³Transplant, Montefiore Medical Center, Bronx, NY, ⁴Montefiore Medical Center, New York, NY, ⁵Einstein-Montefiore Transplant Center, Scarsdale, NY, ⁶Albert Einstein College of Medicine, Montefiore Medical Ctr, Bronx, NY
*Purpose: We aimed to investigate histopathological predictors of graft lost in patients who underwent clinically indicated biopsies for worsening kidney function and/or proteinuria within 3…
2022 American Transplant Congress
Reflections on the Most Prolific United States Kidney Transplant Surgeon: A Career That Helped Define the Standard of Transplant Care
C. Killian¹, R. Reed², P. MacLennan¹, D. Anderson¹, R. Cannon¹, B. Orandi¹, P. Porrett¹, S. Sheikh¹, C. Young¹, M. J. Hanaway¹, J. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Alabama at Birmingham, Irondale, AL
*Purpose: The standard of care in kidney transplantation has evolved with advances in immunosuppressive therapy. Few transplant surgeons experienced the realization of these advances firsthand.…
2022 American Transplant Congress
An Immune-Modulatory Strategy to Mitigate Hepatic Ischemia Reperfusion Injury in a Murine Model
S. Duarte, A. Kobayashi, V. Boominathan, A. Kwiatkowski, J. Simonovich, A. Wanchoo, G. Hudalla, B. Keselowsky, A. Zarrinpar
University of Florida, Gainesville, FL
*Purpose: Hepatic ischemia/reperfusion injury (IRI) is the leading cause of early graft dysfunction and contributes to the shortage of donor liver grafts. However, despite its…
2022 American Transplant Congress
National Attitudes Towards Early Liver Transplantation for Alcoholic Liver Disease
J. Mitchell¹, K. Nijhar¹, K. Herrick-Reynolds², H. Sung¹, P. Chen¹, D. L. Segev¹, E. King¹, A. Cameron¹
¹Department Of Surgery, Johns Hopkins University, Baltimore, MD, ²Department Of Surgery, Walter Reed National Military Medical Center, Bethesda, MD
*Purpose: Pre-transplant abstinence requirements, notably the 6-month sobriety guideline, limit access to liver transplant for patients with severe alcoholic hepatitis (SAH). This study examines the…
2022 American Transplant Congress
Recipient Treatment with Anti-CD122 mAb Prolongs Kidney Allograft Survival During Antibody-Mediated Rejection without Impacting NK Cell Activation within the Graft
D. Okada, S. Miyairi, N. Dvorina, K. S. Keslar, A. Valujskikh, W. Baldwin, R. Fairchild
Cleveland Clinic, Cleveland, OH
*Purpose: Dysregulated donor-specific antibody (DSA) responses are induced in B6.CCR5-/- mice transplanted with complete MHC mismatched kidney allografts and are required for rejection of the…
2022 American Transplant Congress
Covid19 in Pediatric Kidney Transplant Recipients: Incidence, Outcomes, and Response to Vaccine
A. Moudgil, K. Sgambat, Y. Shi, M. Meyers, C. Petyak, L. Midgley
Nephrology, Children's National Med. Ctr., Washington, DC
*Purpose: At the onset of pandemic, no information was available on response of pediatric kidney transplant (PKTX) recipients to COVID19. When COVID19 vaccines became available,…
2022 American Transplant Congress
Ultrasound Assessing Donor Kidney Quality in Deceased Donor Kidney Transplantation
S. Yun¹, K. Lee¹, S. Park², J. Park¹
¹Surgery, Samsung Medical Center, Seoul, Korea, Republic of, ²Radiology and Center for Imaging Science, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: We evaluated the role of functional kidney volume using donor kidney ultrasound (US) alone or in combination with other donor factors and parameters appropriate…
2022 American Transplant Congress
Results Of The Ctot19 Trial: Infliximab (IFX) Induction Does Not Impact 2-year Outcomes In Deceased Donor Kidney Transplant Recipients
P. Heeger¹, B. Armstrong², T. Alhamad³, D. Brennan⁴, J. Bromberg⁵, S. Bunnapradist⁶, S. Chandran⁷, R. Fairchild⁸, D. Foley⁹, R. Formica¹⁰, I. W. Gibson¹¹, D. Hricik¹², K. Kesler², R. B. Mannon¹³, M. Menon¹⁰, K. Newell¹⁴, P. Nickerson¹¹, J. Odim¹⁵, E. Poggio⁸, R. Sung¹⁶, R. Shapiro¹, K. Tinckam¹⁷, F. Vincenti⁷
¹Mount Sinai, New York, NY, ²Rho, Durham, NC, ³Washington U, Saint Louis, MO, ⁴Johns Hopkins, Baltimore, MD, ⁵U Maryland, Baltimore, MD, ⁶UCLA, Los Angeles, CA, ⁷UCSF, San Francisco, CA, ⁸Cleveland Clinic, Cleveland, OH, ⁹U Wisconsin, Madison, WI, ¹⁰Yale, New Haven, CT, ¹¹U Manitoba, Winnipeg, MB, Canada, ¹²U Hosp Case, Cleveland, OH, ¹³U Nebraska, Omaha, NE, ¹⁴Emory, Atlanta, GA, ¹⁵NIAID NIH, Rockville, MD, ¹⁶U Michigan, Ann Arbor, MI, ¹⁷U Hlth Network, Toronto, ON, Canada
*Purpose: Ischemia-reperfusion (IR) of a kidney transplant (KTx) up-regulates tumor necrosis factor alpha (TNF) production within the allograft. IR-induced TNF amplifies post-KTx allograft inflammation and…